DMD transcript imbalance determines dystrophin levels

Rapid, comprehensive analysis of the dystrophin transcript by a custom micro-fluidic exome array

(2011) Matteo Bovolenta et al.   HUMAN MUTATION

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

(2011) Nathalie M. Goemans et al.   NEW ENGLAND JOURNAL OF MEDICINE

Read-Through Strategies for Suppression of Nonsense Mutations in Duchenne/ Becker Muscular Dystrophy: Aminoglycosides and Ataluren (PTC124)

(2010) Richard S. Finkel   JOURNAL OF CHILD NEUROLOGY

Accurate quantification of dystrophin mRNA and exon skipping levels in Duchenne Muscular Dystrophy

(2010) Pietro Spitali et al.   LABORATORY INVESTIGATION

A 3 months mild functional test regime does not affect disease parameters in young mdx mice

(2010) Maaike van Putten et al.   NEUROMUSCULAR DISORDERS

Revertant fibres and dystrophin traces in Duchenne muscular dystrophy: Implication for clinical trials

(2010) Virginia Arechavala-Gomeza et al.   NEUROMUSCULAR DISORDERS

Development of Antisense-Mediated Exon Skipping as a Treatment for Duchenne Muscular Dystrophy

(2009) Hans Heemskerk et al.   Annals of the New York Academy of Sciences

Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population

(2009) Fiona L. M. Norwood et al.   BRAIN

Theoretic applicability of antisense-mediated exon skipping for Duchenne muscular dystrophy mutations

(2009) Annemieke Aartsma-Rus et al.   HUMAN MUTATION

Genotype-phenotype analysis in 2,405 patients with a dystrophinopathy using the UMD-DMD database: a model of nationwide knowledgebase

(2009) Sylvie Tuffery-Giraud et al.   HUMAN MUTATION